What dose-fractionation scheme do you recommend for the treatment of leukemia cutis?
Does your recommendation change based on whether the patient has one or multiple lesions?
2 Answers
Mednet Member
Radiation Oncology · UMass Memorial Medical Group
Answered on · Updated on
Leukemia cutis (LC) is a form of cutaneous extra-medullary leukemia that confers a relatively poor prognosis, with a median survival of <12 months. Since most of these patients have additional sites of involvement (spleen, liver, CNS), the mainstay of treatment of EMD leukemias is still considered t...
Join for free or sign in to see the full answer
Mednet Member
Radiation Oncology · Orlando Health UF Health Cancer Center Health Central Hospital
Answered on
Really thorough answer above. I recently had a case - young guy with AML, with clear marrow but progression in the skin. I consulted with multiple experts in our field at MDACC and KU - was going to do 20 Gy over 5 weeks, which was pretty consistent amongst those I asked. Was going to boost sites of...
Join for free or sign in to see the full answer